the pharmacokinetics and pharmacodynamics of the antiarrhythmic drug , disopyramide , were investigated in 12 volunteers who took 300 mg doses of 3 different capsule preparations and an aqueous oral solution of the drug at 1-week intervals .
C0003195
antiarrhythmic drug
C0012702
disopyramide